This inventor holds 1 USPTO granted patent. Top assignee: Cornell University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Juan Miguel Mosquera: Innovator in Prostate Cancer Detection
Introduction
Juan Miguel Mosquera is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of prostate cancer. His innovative approach combines advanced immunostaining techniques to enhance the accuracy of cancer detection.
Latest Patents
Mosquera holds a patent for his invention titled "ERG/TFF3/HMWCK triple immunostain for detection of prostate cancer." This invention relates to a triple immunostaining assay that allows for sensitive and specific detection of prostate cancer. The assay utilizes positive staining for at least one of ERG or TFF3, combined with negative staining of HMWCK in prostate tissue samples, to indicate the presence of cancer. He has 1 patent to his name.
Career Highlights
Juan Miguel Mosquera is affiliated with Cornell University, where he continues to advance research in cancer diagnostics. His work is pivotal in improving the methodologies used in clinical settings for prostate cancer detection.
Collaborations
Some of his notable coworkers include Mark A Rubin and Kyung Park, who contribute to the research and development of innovative diagnostic techniques.
Conclusion
Juan Miguel Mosquera's contributions to prostate cancer detection through his patented immunostaining assay exemplify the impact of innovation in medical research. His work at Cornell University continues to pave the way for advancements in cancer diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile